University of Illinois at Chicago Research Finds Obese Patients at Risk with Sodium-based AFib Medications

University of Illinois at Chicago Research Finds Obese Patients at Risk with Sodium-based AFib Medications

Dec 1, 2019 | Antiarrhythmic Medications, Atrial Fibrillation, Cardiovascular, Minorities, Obesity, Social Determinants of Health, University of Illinois at Chicago

A new study from researchers at University of Illinois at Chicago reveals that some antiarrhythmic medications used to treat atrial fibrillation (AFib) are less effective in obese patients. Based on an observational study of more than 300 patients in the UIC AFib...

Pin It on Pinterest